Frontiers in Public Health (Mar 2024)

COVID-19 vaccines breakthrough infection and adverse reactions in medical students: a nationwide survey in Iran

  • Amirreza Allahgholipour,
  • Seyed Amir Ahmad Safavi-Naini,
  • Zahra Shekarriz Foomany,
  • Abdolvahab Eskandari,
  • Hossein Nazari Rostami,
  • Mohamad Javad Honarvar,
  • Mohammad Mohammadi,
  • Parnian Khalili,
  • Mehran Ilaghi,
  • Hossein Afshar,
  • Ali Amini Baghbadorani,
  • Hamid Reza Moghimi,
  • Alireza Chamani Goorabi,
  • Amirreza Mehrparvar,
  • Mehdi Safari,
  • Ashraf Sadat Nakhli,
  • Mohammad Mahmoudabadi,
  • Adib Seifadini,
  • Sobhan Sheikhansari,
  • Sadaf Khojastehfar,
  • Parisa Mahdavi,
  • Maede Mohammadi,
  • Siyamak Ashrafi Barzideh,
  • Nadia Akbarzadeh,
  • Seyed Hosein Delavarpour Moghadam,
  • Ali Tavakoli Pirzaman,
  • Mohammad Barary,
  • MohammadAli Emamhadi

DOI
https://doi.org/10.3389/fpubh.2024.1348015
Journal volume & issue
Vol. 12

Abstract

Read online

IntroductionThere are different types of COVID-19 vaccines approved worldwide. Since no national studies focus on vaccine-related adverse reactions and breakthrough cases, this study aimed to investigate the rate of adverse events and COVID-19 infection in medical students in Iran.MethodsThis retrospective cohort study included Iranian medical students who received two doses of COVID-19 vaccines. The medical team gathered the demographic characteristics, comorbidities, type of vaccine, adverse events following vaccination, and history of COVID-19 infection data through a phone interview. The frequency of adverse events and breakthrough infection was stratified by vaccine type (ChAdOx1-S, Gam-COVID-Vac, and BIBP-CorV).ResultsA total of 3,591 medical students enrolled in this study, of which 57.02% were females, with a mean age of 23.31 + 4.87. A PCR-confirmed and suspicious-for-COVID-19 breakthrough infection rate of 4.51 and 7.02% was detected, respectively. There was no significant relation between breakthrough infection and gender, BMI, blood groups, and comorbidities. However, there was a significant difference in breakthrough infection rate among different types of vaccines (p = 0.001) and history of COVID-19 infection (p = 0.001). A total of 16 participants were hospitalized due to COVID-19 infection after vaccination for reasons such as dyspnea, abnormal imaging, or decreased oxygen saturation. No severe infection or death was observed in the studied population.ConclusionVaccination prevented severe COVID-19 infection, although a high breakthrough infection rate was evident among Iranian medical students during the Delta variant’s peak. Vaccine effectiveness may be fragile during emerging new variants and in high-exposure settings. Moreover, adverse events are rare, and the benefits of vaccination outweigh the side effects. However, many limitations challenged this study, and the results should be cautious.

Keywords